Clinical trial for Pelvic Pain
Official title Personalized Exercise Recommendations for Chronic Pelvic Pain Using Reinforcement Learning
ClinicalTrials.gov ID: NCT07810218
What this study is testing
- What it's testing
- WorkoutCPP is a pilot study evaluating the feasibility of a personalized exercise recommendation system for individuals with chronic pelvic pain disorders (CPPDs). The study uses reinforcement learning (RL), a type of artificial intelligence that adapts recommendations over time based on each participant's reported pain levels, symptom burden, and exercise compliance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 55, women only
You may be able to join if
- Self-reported CPPD (e.g., endometriosis, adenomyosis, fibroids, etc.) based on clinician diagnosis
- Aged 18-55 years.
- Ownership of an iOS or Android smartphone.
- Willingness to self-track daily symptoms, exercise activities, and self-management behaviors using a smartphone research app.
- Willingness to wear an activity tracker for the study duration.
You likely can't join if
- Absolute contraindications to PA (e.g., recent myocardial infarction, complete heart block, acute congestive heart failure, unstable angina, or...
- More than two "Yes" responses on the Physical Activity Readiness Questionnaire (PAR-Q) (16) without physician clearance.
- Major life events expected during the next 10 weeks (e.g., pregnancy, planned surgery, or extended travel likely to interfere with participation).
- Current or planned pregnancy within the next 6 months.
- Having given birth in the past 6 months or currently nursing.
- Inability to wear an activity tracker or use the app for the study duration.
See the full eligibility criteria
- Self-reported CPPD (e.g., endometriosis, adenomyosis, fibroids, etc.) based on clinician diagnosis
- Aged 18-55 years.
- Ownership of an iOS or Android smartphone.
- Willingness to self-track daily symptoms, exercise activities, and self-management behaviors using a smartphone research app.
- Willingness to wear an activity tracker for the study duration.
- Willingness to follow exercise recommendations from a smartphone research app, provided no adverse symptoms occur.
- Ability to read and write in English sufficient to understand study materials and communications.
- At least intermittently physically active (e.g., ≥30 minutes of walking twice per week).
- Absolute contraindications to PA (e.g., recent myocardial infarction, complete heart block, acute congestive heart failure, unstable angina, or uncontrolled severe hypertension, BP ≥180/110 mm Hg).
- More than two "Yes" responses on the Physical Activity Readiness Questionnaire (PAR-Q) (16) without physician clearance.
- Major life events expected during the next 10 weeks (e.g., pregnancy, planned surgery, or extended travel likely to interfere with participation).
- Current or planned pregnancy within the next 6 months.
- Having given birth in the past 6 months or currently nursing.
- Inability to wear an activity tracker or use the app for the study duration.
- Complete inactivity (i.e., \<60 minutes of moderate-intensity PA per week).
The study team makes the final eligibility decision.
Where it's taking place
- New York, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 55 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New York, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.